Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
308 GBX | -0.65% | +3.53% | +8.83% |
Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
Apr. 26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited